Connecting you to content on EBSCOhost

Works matching IS 17588340 AND DT 2014 AND VI 6 AND IP 5

Results: 5

1

Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications.

Published in:

Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 210, doi. 10.1177/1758834014535650

By:

Pernas Simon, Sonia

Publication type:

Article

2

Novel agents in development for advanced non-small cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 240, doi. 10.1177/1758834014532510

By:

Stinchcombe, Thomas E.

Publication type:

Article

3

Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy.

Published in:

Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 222, doi. 10.1177/1758834014544892

By:

Ferraro, Danielle;
Zalcberg, John

Publication type:

Article

4

Treatment options in recurrent ovarian cancer: latest evidence and clinical potential.

Published in:

Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 229, doi. 10.1177/1758834014544121

By:

Luvero, Daniela;
Milani, Andrea;
Ledermann, Jonathan A.

Publication type:

Article

5

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential.

Published in:

Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 202, doi. 10.1177/1758834014539183

By:

Peddi, Parvin F.;
Hurvitz, Sara A.

Publication type:

Article